Clinical trial
Safety Study of Pioglitazone Compared To Glyburide on Liver Function
NCT00494312 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00494312 |
|---|---|
| Title | Safety Study of Pioglitazone Compared To Glyburide on Liver Function |
| Official title | A Randomized, Comparator Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCl vs Glyburide With Metformin and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent) Diabetes |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Liver |
| Intervention type | Drug |
| Interventions | Pioglitazone, Glyburide |
| Enrollment | 2,120 |
| Start date | Oct 1, 2000 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Jun 29, 2007 |
| Last update posted | Feb 28, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: